Interleukin-2 - CISMeF

Preferred Label : Interleukin-2;

MeSH definition : A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes.;

MeSH synonym : t-cell stimulating factor; t cell stimulating factor; interleukine 2; lymphocyte mitogenic factor; tcgf; il-2; il2; mitogenic factor, lymphocyte; t-cell growth factor; t cell growth factor; thymocyte stimulating factor; interleukin ii; interleukin 2;

MeSH hyponym : RU 49637; Ro-23-6019; Ro 23 6019; Ro236019; Ro-236019; Ro 236019; RU-49637; RU49637;

MeSH annotation : DF: IL 2 or IL2;

Wikipedia link : https://en.wikipedia.org/wiki/Interleukin 2;

Is substance : O;

Details

Origin ID

D007376;

UMLS CUI

C0021756;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Burkina Faso [NCIt concept]
- CFB wt Allele [NCIt concept]
- GPI wt Allele [NCIt concept]
- Glucose-6-Phosphate Isomerase [NCIt concept]
- IL2 Gene [NCIt concept]
- Interleukin [NCIt concept]
- Interleukin [FMA entity]
- Interleukin (substance) [SNOMED CT concept]
- Interleukin 2 [OMIM gene]
- Interleukin 2 Measurement [NCIt concept]
- Interleukin-10 [NCIt concept]
- Interleukin-6 [NCIt concept]
- Mycosis Fungoides [NCIt concept]
- Myotonia Fluctuans [NCIt concept]
- PEG-interleukin-2 [NCIt concept]
- Product containing interleukin-2 (medicinal product) [SNOMED CT concept]
- Saint Martin (French Part) [NCIt concept]
- interleukin 2 [HGNC gene]
- interleukin 2 [COVID-19 Thesaurus concept]
- interleukin, nos [SNOMED Notion]
- interleukin-2 receptor binding [GO term]
- interleukins [ATC Code]
False automatic mappings
- Marfan syndrome [ORDO Disease]
Indexing information
- EMD 521873 [MeSH Supplementary Concept]
- F8-IL2 immunocytokine [MeSH Supplementary Concept]
- NHS76-PEP2 [MeSH Supplementary Concept]
- PHILIP protein, human [MeSH Supplementary Concept]
- cytoplasmic activator protein, human [MeSH Supplementary Concept]
- interleukin 2 inhibitor [MeSH Supplementary Concept]
Pharmacological action(s)
- analgesics, non-narcotic [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
Record concept(s)
- Interleukin-2 [MeSH concept]
- RU 49637 [MeSH concept]
- Ro-23-6019 [MeSH concept]
Related MeSH Supplementary Concept(s)
- ALT-801 [MeSH Supplementary Concept]
- Ala(125)-interleukin 2 [MeSH Supplementary Concept]
- DAB(486)-interleukin 2 [MeSH Supplementary Concept]
- E7777 fusion protein [MeSH Supplementary Concept]
- F42A [MeSH Supplementary Concept]
- IL-2-PE40 chimeric protein, recombinant [MeSH Supplementary Concept]
- IL2 protein, human [MeSH Supplementary Concept]
- IL233 fusion protein [MeSH Supplementary Concept]
- N-(4-fluorobenzoyl)interleukin-2 [MeSH Supplementary Concept]
- aldesleukin [MeSH Supplementary Concept]
- bempegaldesleukin [MeSH Supplementary Concept]
- denileukin diftitox [MeSH Supplementary Concept]
- interleukin 2, glycosylated [MeSH Supplementary Concept]
- interleukin 2-PE66(4Glu) protein, recombinant [MeSH Supplementary Concept]
- interleukin 2-diphtheria toxin [MeSH Supplementary Concept]
- interleukin-2 (22-58) [MeSH Supplementary Concept]
- interleukin-2 (59-72) [MeSH Supplementary Concept]
- interleukin-2 (66-72) [MeSH Supplementary Concept]
- interleukin-2, polyethylene glycol-modified [MeSH Supplementary Concept]
- interleukin-2, succinyl- [MeSH Supplementary Concept]
- lorukafusp alfa [MeSH Supplementary Concept]
- methionyl interleukin-2, alanine(125)- [MeSH Supplementary Concept]
- oncolipin [MeSH Supplementary Concept]
- peptide C-I-6 [MeSH Supplementary Concept]
- recombinant fusion protein IL-6 - IL-2 [MeSH Supplementary Concept]
- recombinant fusion protein RNase1-IL-2 [MeSH Supplementary Concept]
- technetium tc 99m interleukin 2 [MeSH Supplementary Concept]
- tucotuzumab celmoleukin [MeSH Supplementary Concept]
See also
- killer cells, lymphokine-activated [MeSH Descriptor]
- receptors, interleukin-2 [MeSH Descriptor]
- t-lymphocytes, helper-inducer [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- Interleukin 2 [LOINC component]
- Interleukin-2 [FMA entity]
- Interleukin-2 [NCIt concept]
- Interleukin-2 (substance) [SNOMED CT concept]
- Product containing interleukin-2 (medicinal product) [SNOMED CT concept]
- interleukin-2 [SNOMED Notion]
- lymphocyte mitogenic factor [SNOMED Notion]
Validated automatic mappings to BTNT
- Interleukin-2, recombinant [SMS substance]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients